Company news
Insmed Incorporated news in 2021
Insmed Incorporated's news releases, calls and decks from 2021, newest first.
Insmed To Participate in Three November Conferences
November 2, 2021
Insmed Reports Third Quarter 2021 Financial Results and Provides Business Update
October 27, 2021
Insmed Ranks No. 1 on Science's 2021 Top Biopharma Employers List
October 27, 2021
Insmed to Host Third Quarter 2021 Financial Results Conference Call on Thursday, October 28, 2021
October 13, 2021
Insmed To Participate in Five September Conferences
August 31, 2021
Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
August 4, 2021
Insmed to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021
July 26, 2021
Insmed To Present at Two June Conferences
May 24, 2021
Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference
May 18, 2021
Insmed Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes and Full Exercise of Underwriters' Options to Purchase Additional Shares and Notes
May 12, 2021
Insmed Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
May 10, 2021
Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028
May 9, 2021
Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
May 5, 2021
Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021
April 21, 2021
ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR
March 22, 2021
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 24, 2021
Insmed to Present at Two March Conferences
February 23, 2021
Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)
February 18, 2021
Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 Study
February 15, 2021
Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021
February 11, 2021
Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 4, 2021
Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with MAC Lung Disease
January 3, 2021
Calls in 2021
Decks in 2021
- Technical Presentation (February 2021)
Technical · 23 slides · Feb 19, 2021
- Investor Presentation (January 2021)
Investor deck · 51 slides · Jan 11, 2021